Offer - Urjas Oil for just ₹ 1
Endoxan Asta 1000 Injection is a prescription medicine that is available as a Injection. It is typically used for the treatment of Ovarian Cancer, Multiple Myeloma. Endoxan Asta 1000 Injection also has some secondary and off-label uses. These are listed below.
The correct dosage of Endoxan Asta 1000 Injection depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
Apart from the aforementioned side effects, Endoxan Asta 1000 Injection can also lead to other problems, which have been listed below. Usually, these side effects of Endoxan Asta 1000 Injection go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
Endoxan Asta 1000 Injection's effect during pregnancy is Severe and Severe while nursing. In addition, Endoxan Asta 1000 Injection's effects on the liver, heart and kidney are discussed below in the Endoxan Asta 1000 Injection related warnings section.
Other conditions have been mentioned below in the Endoxan Asta 1000 Injection contraindications section.
Besides this, Endoxan Asta 1000 Injection may also have severe interaction with some medicines. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Endoxan Asta 1000 Injection is considered not safe while driving, and is not addictive.
Endoxan Asta 1000 Injection is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult(Female) |
|
Geriatric |
|
Adult |
|
Is the use of Endoxan Asta 1000 Injection safe for pregnant women?
Pregnant women may get severe side effects after taking Endoxan. If you are pregnant, do not take Endoxan without a doctor's advice.
Is the use of Endoxan Asta 1000 Injection safe during breastfeeding?
Taking Endoxan may lead to serious side effects if you are breastfeeding. Endoxan should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Endoxan Asta 1000 Injection on the Kidneys?
Endoxan rarely harms the kidneys.
What is the effect of Endoxan Asta 1000 Injection on the Liver?
Endoxan is rarely harmful for the liver.
What is the effect of Endoxan Asta 1000 Injection on the Heart?
Endoxan may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Endoxan Asta 1000 Injection unless your doctor advises you to do so -
Is this Endoxan Asta 1000 Injection habit forming or addictive?
Endoxan Asta 1000 Injection is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Endoxan Asta 1000 Injection you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Endoxan Asta 1000 Injection should be used only after doctor's advice.
Is it able to treat mental disorders?
Endoxan Asta 1000 Injection is unable to treat or cure mental disorders.
Interaction between Food and Endoxan Asta 1000 Injection
Taking Endoxan Asta 1000 Injection with food is safe.
Interaction between Alcohol and Endoxan Asta 1000 Injection
Due to lack of research, there is no information about the side effects of taking Endoxan Asta 1000 Injection with alcohol.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Cyclophosphamide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 860
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 375-377